PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer

PURPOSE: Small-cell lung cancer (SCLC) is an aggressive high-grade neuroendocrine tumor with limited treatment strategies. Programmed death 1 (PD-1) and its ligand (PD-L1), delta-like ligand-3 (DLL-3), and poly ADP-ribose polymerase (PARP) inhibitors have shed light on the treatment of extensive sta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Fu, Xiao, Liu, Zhiyan, Xiang, Luochengling, Liu, Mengjie, Zheng, Xiaoqiang, Wang, Jingjing, Liu, Na, Gao, Huan, Jiang, Aimin, Yang, Yujuan, Liang, Xuan, Ruan, Zhiping, Tian, Tao, Yao, Yu
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7608588/
https://ncbi.nlm.nih.gov/pubmed/33154673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S260599
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars